【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2013 9
2.2.1 Biogen Idec to Acquire Elan’s Interest in Multiple Sclerosis Drug Tysabri for $3.2 Billion 9
2.2.2 Cardinal Health to Acquire AssuraMed for Up to $2.07 Billion 10
2.2.3 Mylan to Acquire Agila Specialties from Strides Arcolab for Up to $1.85 Billion 10
2.2.4 Quintiles Transnational Files Registration Statement for IPO to Raise Up to $600 Million 10
2.2.5 Chiasma Enters into Licensing Agreement with Roche for Octreolin 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2013 14
3.1.1 Top M&A Deals in February 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2012–February 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2013 17
3.2.1 Top Equity Offering Deals in February 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2012 – February 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2013 20
3.3.1 Top PE/VC Deals in February 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2012 – February 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2012 – February 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2012 – February 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2012 – February 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2012 – February 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2012 – February 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2012 – February 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2013 47
6.2.1 Central Nervous System – Deals of the Month 48
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2013 49
6.3.1 Immunology – Deal of the Month 50
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2013 51
6.4.1 Infectious Diseases – Deals of the Month 52
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2013 53
6.5.1 Metabolic Disorders – Deal of the Month 54
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2013 55
6.6.1 Cardiovascular – Deal of the Month 56
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, February 2013 57
6.7.1 Respiratory – Deal of the Month 58
7 Deal Summary by Geography 59
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2013 59
7.1.1 North America – Deals of the Month 60
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2013 62
7.2.1 Europe – Deals of the Month 63
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2013 65
7.3.1 Asia-Pacific – Deals of the Month 66
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2013 67
7.4.1 Rest of the World – Deals of the Month 68
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 69
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2012 – February 2013 69
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2012 – February 2013 70
9 Further Information 71
9.1 Methodology 71
9.2 About GlobalData 71
9.3 Contact Us 72
9.4 Disclosure information 72
9.5 Disclaimer 72
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：February 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
■ 発行日：2013年3月12日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160588
■ 調査対象地域：グローバル
- 世界のエチレン産業動向Global Ethylene Industry - Feedstock Advantage Shifts New Investments to the US Summary GlobalData, the industry analysis specialist, has released its latest research, “Global Ethylene Industry - Feedstock Advantage Shifts New Investments to the US”. The study comes from the company’s oil and gas research group and provides market analysis of the global ethylene industry, highlighting major featur …
- 世界のサファイアガラス市場2015The Global Sapphire Glass Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Sapphire Glass industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sapphire Glass market analysis is provided for the international markets including development trends, compe …
- 筆記・マーキング用具の世界市場2017-2021：ペン、鉛筆、彩色用具、マーカー・ハイライトマーカー、筆記用具アクセサリAbout Writing and Marking InstrumentsAmong stationery products, writing instruments, used by all age groups, primarily have universal application in academic, corporate, and personal requirements. However, despite increased use of gadgets and digitalization for the same purpose on a different medium instead of paper-based material, the market is expected to grow. This is owing to initiatives, such …
- 機関車用前照システムの世界市場2017-2021About Locomotive Front Lighting System Lighting systems are mainly used for providing visual convenience during night travels and for representing different signals in a locomotive. Lighting systems for locomotives are different from the conventional lighting systems used in automotive, aircraft, or marine applications. Front lighting systems developed for locomotives must be able to function effe …
- 航空機改装の世界市場2015-2022According to Stratistics MRC, the Global Aircraft Refurbishing market is accounted for $3.7 billion in 2015 and is expected to reach $5.8 billion by 2022 growing at a CAGR of 6.5% from 2015 to 2022. Increasing requirement for huge business, VIP aircraft and advancements in technologies are the key factors fueling the demand for aircraft refurbishing market growth. Increasing demand for revamp and …
- 包装自動化ソリューションの世界市場予測（～2022）：製品種類別（自動包装装置、包装ロボット、自動コンベア、仕分けシステム）、機能別（ケース梱包、パレタイジング）、ソフトウェア・サービス別、産業別、地域別The packaging automation solution market was valued at USD 28.39 Billion in 2015 and is expected to reach USD 52.42 Billion by 2022, growing at a CAGR of 8.68% during the forecast period. The increasing adoption of automation solutions across various industries, increasing need for supply chain integration, and reduction in labor costs are the major drivers for the packaging automation solution ma …
- 世界主要国におけるRSウイルス（呼吸器合抱体ウイルス）検査市場2015The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: …
- 世界のエピネフリン自動注入装置市場動向（2012-2016）TechNavio's analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of allergies. The Global Epinephrine Auto-injector market has also been witnessing the development of chlorofluorocarbon-free epinephrine auto-injector inhalers. However, the ad …
- フェンシング用品の世界市場2016-2020About Fencing Fencing is a sport in which two competitors fight using rapier-style swords that are called weapons; each competitor earns points by making contact with his or her opponent. To win, the participants have to score 15 points (in the case of elimination matches) or five points (in the case of preliminary matches) before their opponents. Technavio’s analysts forecast the global fencing e …
- グローライトの世界市場2019-2023Global Grow Light Market: About this market Technavio’s grow light market analysis considers sales from HID lights, LED lights, fluorescent lights, and others. Our analysis also considers the sales of grow light in APAC, Europe, North America, South America, and MEA. In 2018, the HID light segment had a significant market share. However, the LED light segment will have the largest market share dur …
- 扁桃炎(Tonsillitis)：世界の治験レビュー2014年下半期版Tonsillitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Tonsillitis Global Clinical Trials Review, H2, 2014" provides data on the Tonsillitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tonsillitis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- Salmonella：医療検査市場2014The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - P …
- 世界の3Dスキャン市場：光学、レーザー、立体照明3D scanning is one of the growing areas of applications amongst a wide range of 3D technologies. This technology is well suited for complex geometries that require a high degree of precision. This precision technology generates highly accurate and quick results, as it uses a laser beam for capturing digital information about the shape of any physical object. The technology is widely adopted in var …
- プラスチック用添加剤の世界市場：可塑剤、安定剤、難燃剤、耐衝撃性改良剤Additives are added in plastics to improve its impact strength, chemical and heat resistance, clarity, weather resistance and color preservation properties. Plastic additives are used to add volume in order to control costs, modify the physical or chemical properties of the polymer, or reinforcing the polymer’s mechanical properties to make it stronger and better for end-use applications. Plastics …
- セルフペース型eラーニングの世界市場2016-2020About the Generic E-Learning Courses Market E-learning refers to learning through electronic gadgets, such as PCs, notebooks, and tablets. It is backed by ICT that enables users to learn 24/7 learning from any access point. The curriculum of e-learning includes archived and real-time information. There is no set standard of e-learning method used in the education market. Differentiation is primari …
